title: Potential therapeutic role of phosphodiesterase type 5 inhibition in hypertension and chronic kidney disease.
authors.affiliation: Clinical Pharmacology Unit, British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Room E3.22, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland, United Kingdom. D.J.Webb@ed.ac.uk.
authors.forename: Kayleigh E
authors.initials: KE
authors.lastname: Brown
authors.forename: Neeraj
authors.initials: N
authors.lastname: Dhaun
authors.forename: Jane
authors.initials: J
authors.lastname: Goddard
authors.forename: David J
authors.initials: DJ
authors.lastname: Webb
mesh_terms: D002319:Cardiovascular System / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism*; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D009569:Nitric Oxide